Form 4: DENTSPLY SIRONA Director Brian Gladden Increases Stake Through RSU Dividends

DENTSPLY SIRONA Inc. Director Brian T. Gladden acquired 222.26 shares of common stock as dividends on restricted stock units, increasing his beneficial ownership to 28,440.469 shares.

Summary

• Brian T. Gladden, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 222.26 shares of common stock on July 11, 2025.
• The acquisition was a dividend on restricted stock units (RSUs) previously awarded to Mr. Gladden.
• These new shares were acquired at a price of $0, indicating they were part of a compensation or dividend distribution, not a purchase.
• The acquired shares are in the form of additional RSUs and are subject to the same vesting terms as the underlying awards.
• The dividends vest simultaneously with the RSUs to which they relate, and each RSU converts to common stock on a 1:1 basis.
• Following this transaction, Brian T. Gladden beneficially owns a total of 28,440.469 shares of DENTSPLY SIRONA Inc. common stock.
• A Limited Power of Attorney was granted by Brian T. Gladden on May 22, 2025, authorizing Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute and file Section 16 reports (Forms 3, 4, and 5) on his behalf.

Sentiment

Score: 7

Explanation: The document reports a routine insider transaction involving the acquisition of shares through RSU dividends, which is a standard compensation event. It is neutral to slightly positive as it increases the director's ownership stake.

Positives

• The acquisition of additional shares, even as dividends, increases the director's stake in the company, aligning his interests further with shareholders.
• The transaction represents a routine compensation event for the director, indicating adherence to established RSU programs.

Future Outlook

No specific forward-looking statements or guidance are provided beyond the vesting terms of the RSU dividends.

Industry Context

This filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects standard executive compensation practices within publicly traded companies.

Corporate Governance

Stakeholder Impact

• Shareholders: The transaction slightly increases the director's ownership, aligning his interests with long-term shareholder value.
• Management/Employees: Reflects standard compensation practices for directors.

Key Dates

Keywords

DENTSPLY SIRONA, XRAY, Form 4, insider transaction, restricted stock units, RSU dividends, stock acquisition, Brian T. Gladden, corporate governance